Sumiyuki Nishida

Induction of <i>WT1</i> (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

Akihiro Tsuboi, Tetsuya Taguchi, Tadashi Osaki et al. · Proceedings of the National Academy of Sciences · 2004 · 524 citations · Full text

Cytotoxic T Lymphocytes, Wt1 Peptide, Immune Regulation +24

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

Hiroyasu Ogawa, Hiroya Tamaki, Kazuhiro Ikegame et al. · Blood · 2003 · 224 citations · Full text

Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme

Shuichi Izumoto, Akihiro Tsuboi, Tsuyoshi Suzuki et al. · Journal of neurosurgery · 2008 · 208 citations

Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study

Takayuki Shiroyama, Izumi Nagatomo, Shohei Koyama et al. · Scientific Reports · 2019 · 162 citations · Full text

The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy

Naoki Hosen, Yukiko Matsunaga, Kana Hasegawa et al. · Nature Medicine · 2017 · 139 citations

Cancer Immunosurveillance, Immunology, Cellular Immune Response +5